Levoquin: Advanced Antibiotic Therapy for Severe Bacterial Infections
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.71 | $51.39 (0%) | 🛒 Add to cart |
| 60 | $1.51 | $102.77 $90.68 (12%) | 🛒 Add to cart |
| 90 | $1.31 | $154.16 $117.89 (24%) | 🛒 Add to cart |
| 120 | $1.16 | $205.54 $139.04 (32%) | 🛒 Add to cart |
| 180 | $1.01 | $308.32 $181.36 (41%) | 🛒 Add to cart |
| 270 | $0.91 | $462.48 $244.84 (47%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $616.63 $315.37 (49%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.02 | $40.30 (0%) | 🛒 Add to cart |
| 30 | $1.91 | $60.45 $57.43 (5%) | 🛒 Add to cart |
| 60 | $1.81 | $120.91 $108.82 (10%) | 🛒 Add to cart |
| 90 | $1.66 | $181.36 $149.12 (18%) | 🛒 Add to cart |
| 120 | $1.51 | $241.82 $181.36 (25%) | 🛒 Add to cart |
| 180 | $1.26 | $362.73 $226.70 (37%) | 🛒 Add to cart |
| 270 | $1.14 | $544.09 $307.31 (44%) | 🛒 Add to cart |
| 360 | $1.04
Best per pill | $725.45 $372.80 (49%) | 🛒 Add to cart |
Levoquin (levofloxacin) is a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of adults with serious bacterial infections. As the optically active L-isomer of ofloxacin, it demonstrates enhanced antibacterial activity against a wide range of gram-positive and gram-negative pathogens. This medication is specifically formulated for cases where first-line antibiotics have proven ineffective or are contraindicated. Proper diagnosis and antimicrobial susceptibility testing are essential before initiating therapy to ensure appropriate use and minimize resistance development.
Features
- Contains levofloxacin as the active pharmaceutical ingredient
- Available in oral tablets (250mg, 500mg, 750mg) and intravenous solution
- Broad-spectrum activity against aerobic gram-positive and gram-negative bacteria
- Excellent tissue penetration and bioavailability
- Once-daily dosing regimen for most indications
- Demonstrated efficacy in complicated urinary tract infections, pneumonia, and skin structure infections
Benefits
- Provides potent bactericidal action against resistant pathogens
- Offers convenient once-daily dosing that improves patient compliance
- Demonstrates excellent penetration into lung tissue, prostate, and other difficult-to-treat sites
- Effective against both community-acquired and hospital-acquired infections
- Rapid onset of action with predictable pharmacokinetics
- Available in both oral and intravenous formulations for seamless transition between care settings
Common use
Levoquin is prescribed for the treatment of adults with complicated urinary tract infections, including pyelonephritis, caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis. It is also indicated for community-acquired pneumonia due to Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or atypical pathogens. Additional approved uses include complicated skin and skin structure infections, chronic bacterial prostatitis, acute bacterial sinusitis, and inhalational anthrax exposure. Healthcare providers should reserve Levoquin for these conditions when alternative treatment options are limited.
Dosage and direction
The dosage of Levoquin varies according to the type and severity of infection, renal function, and patient characteristics. For most indications in patients with normal renal function (creatinine clearance ≥50 mL/min), the recommended dose is 250-750 mg once every 24 hours. The duration of treatment typically ranges from 7 to 14 days, depending on the infection type and clinical response. Patients should take Levoquin tablets at the same time each day, with a full glass of water, and may be taken with or without food. For patients with renal impairment, dosage adjustment is necessary based on creatinine clearance. Intravenous administration should be infused slowly over 60 minutes to minimize vein irritation.
Precautions
Patients should be advised that Levoquin may cause dizziness and lightheadedness; therefore, caution should be exercised when driving or operating machinery. Tendon inflammation and rupture may occur during or after therapy, particularly in elderly patients, those taking corticosteroids, and patients with kidney, heart, or lung transplants. Discontinue Levoquin immediately if pain, inflammation, or rupture of a tendon occurs. Photosensitivity reactions may appear; patients should avoid excessive sunlight and artificial UV light and use protective clothing and sunscreen. Blood glucose disturbances may occur, especially in diabetic patients; monitor blood glucose regularly. Periodic assessment of organ system functions is recommended during prolonged therapy.
Contraindications
Levoquin is contraindicated in patients with known hypersensitivity to levofloxacin, other quinolone antibiotics, or any component of the formulation. It should not be used in patients with a history of tendon disorders related to fluoroquinolone administration. Concomitant administration with tizanidine is contraindicated due to the risk of potentiated hypotensive and sedative effects. Levoquin is not recommended for pediatric patients, pregnant women, or nursing mothers unless the potential benefits outweigh the risks. Patients with known prolongation of the QT interval, uncorrected hypokalemia, or those taking Class IA or III antiarrhythmic agents should avoid Levoquin therapy.
Possible side effect
The most frequently reported adverse reactions include nausea (1.2%), diarrhea (1.1%), headache (0.9%), and constipation (0.8%). Less common but more serious side effects may include tendonitis or tendon rupture, peripheral neuropathy, central nervous system effects ( dizziness, insomnia, depression), QT interval prolongation, and hypersensitivity reactions. Musculoskeletal disorders such as arthralgia and myalgia have been reported. Hepatic enzyme elevations and photosensitivity reactions may occur. Pseudomembranous colitis has been reported with nearly all antibacterial agents, including Levoquin. Patients should report any unusual symptoms promptly to their healthcare provider.
Drug interaction
Levoquin may interact with several medications, including antacids containing magnesium or aluminum, sucralfate, metal cations such as iron, and multivitamins containing zinc, which may significantly reduce absorption. Concurrent use with nonsteroidal anti-inflammatory drugs may increase the risk of CNS stimulation and seizures. Levoquin may enhance the effects of warfarin; monitor prothrombin time and INR closely. Concomitant use with drugs that prolong the QT interval (antiarrhythmics, antipsychotics, antidepressants, macrolides) may result in additional prolongation. Levoquin may affect blood glucose levels when used with antidiabetic agents, requiring close monitoring. Dose adjustment may be necessary when administered with probenecid.
Missed dose
If a dose of Levoquin is missed, patients should take it as soon as they remember, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed dose. Maintaining consistent antibiotic blood levels is important for therapeutic efficacy, so adherence to the prescribed schedule is strongly recommended. If multiple doses are missed, patients should contact their healthcare provider for guidance.
Overdose
In case of overdose, symptomatic treatment should be instituted. ECG monitoring is recommended due to the possibility of QT interval prolongation. Adequate hydration should be maintained. Levoquin is not effectively removed by hemodialysis or peritoneal dialysis. Specific antidotes are not available. Management of overdose should include general supportive measures and monitoring of vital signs. Patients should be observed for signs of CNS stimulation, including seizures, and appropriate anticonvulsant therapy instituted if necessary. Gastrointestinal decontamination with activated charcoal may be considered if ingestion was recent.
Storage
Store Levoquin tablets at controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the medication in its original container, tightly closed, and protected from light and moisture. Do not store in the bathroom or near sinks. Keep all medications out of reach of children and pets. Do not use Levoquin after the expiration date printed on the packaging. Properly discard any unused medication according to local regulations or through drug take-back programs.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Levoquin is a prescription medication that should be used only under the supervision of a qualified healthcare professional. The prescribing physician should be consulted for diagnosis and treatment decisions. Individual results may vary, and not all patients will experience the same benefits or side effects. Patients should not discontinue or change their dosage without medical consultation. Full prescribing information including boxed warnings should be reviewed before initiation of therapy.
Reviews
Clinical studies have demonstrated Levoquin’s efficacy in treating various bacterial infections, with clinical success rates ranging from 85% to 95% across different indications. Healthcare providers report satisfactory outcomes in complicated infections where other antibiotics have failed. Some clinicians note the importance of appropriate patient selection and monitoring for adverse effects. Patients generally appreciate the once-daily dosing convenience, though some report gastrointestinal side effects. The medical community continues to emphasize the importance of reserving Levoquin for appropriate indications to combat antimicrobial resistance. Post-marketing surveillance continues to provide valuable real-world data on safety and effectiveness profiles.